KNT
pranlukast
Created: | 2019-06-12 |
Last modified: | 2019-10-30 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 59 |
Chiral Atom Count | 0 |
Bond Count | 63 |
Aromatic Bond Count | 23 |
Chemical Component Summary | |
---|---|
Name | pranlukast |
Systematic Name (OpenEye OEToolkits) | ~{N}-[4-oxidanylidene-2-(1~{H}-1,2,3,4-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide |
Formula | C27 H23 N5 O4 |
Molecular Weight | 481.503 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | O=C(Nc1cccc2C(=O)C=C(Oc12)c3[nH]nnn3)c4ccc(OCCCCc5ccccc5)cc4 |
SMILES | OpenEye OEToolkits | 2.0.7 | c1ccc(cc1)CCCCOc2ccc(cc2)C(=O)Nc3cccc4c3OC(=CC4=O)c5[nH]nnn5 |
Canonical SMILES | CACTVS | 3.385 | O=C(Nc1cccc2C(=O)C=C(Oc12)c3[nH]nnn3)c4ccc(OCCCCc5ccccc5)cc4 |
Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1ccc(cc1)CCCCOc2ccc(cc2)C(=O)Nc3cccc4c3OC(=CC4=O)c5[nH]nnn5 |
InChI | InChI | 1.03 | InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32) |
InChIKey | InChI | 1.03 | NBQKINXMPLXUET-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB01411 |
---|---|
Name | Pranlukast |
Groups | investigational |
Description | Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens. |
Synonyms |
|
Indication | Used as an adjunct to the standard therapy of inhaled steroids with inhaled long- and/or short-acting beta-agonists. |
Categories |
|
ATC-Code | R03DC02 |
CAS number | 103177-37-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Cysteinyl leukotriene receptor 1 | MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIK... | unknown | antagonist |
Tumor necrosis factor | MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCL... | unknown | other/unknown |
Interleukin-5 | MRMLLHLSLLALGAAYVYAIPTEIPTSALVKETLALLSTHRTLLIANETL... | unknown | antagonist |
Eosinophil cationic protein | MVPKLFTSQICLLLLLGLMGVEGSLHARPPQFTRAQWFAIQHISLNPPRC... | unknown | other/unknown |
Nuclear factor NF-kappa-B p105 subunit | MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQP... | unknown | other/unknown |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL21333 |
PubChem | 4887 |
ChEMBL | CHEMBL21333 |
ChEBI | CHEBI:94810 |